Clinical trial
An Observational National Pediatric Study on Prevalence of Unexplained Splenomegaly
NCT04845958 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational National Pediatric Study on Prevalence of Unexplained Splenomegaly
- Lead sponsor
- Sanofi
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2021
- Completion date
- November 25, 2024
- Enrollment
- 60 (actual)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.
acid sphingomyelinase deficiency, gaucher disease, splenomegaly